Police & Firemen s Retirement System of New Jersey Acquires 972 Shares of Veeva Systems Inc. $VEEV

Police & Firemen s Retirement System of New Jersey raised its holdings in Veeva Systems Inc. (NYSE:VEEV) by 4.5% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 22,370 shares of the technology company’s stock after acquiring an additional 972 shares during the quarter. Police & Firemen s Retirement System of New Jersey’s holdings in Veeva Systems were worth $6,442,000 at the end of the most recent quarter.

Several other hedge funds also recently modified their holdings of the business. ASR Vermogensbeheer N.V. boosted its holdings in Veeva Systems by 64.2% in the 2nd quarter. ASR Vermogensbeheer N.V. now owns 5,167 shares of the technology company’s stock valued at $1,488,000 after purchasing an additional 2,020 shares during the period. Merit Financial Group LLC grew its position in Veeva Systems by 12.5% during the second quarter. Merit Financial Group LLC now owns 45,247 shares of the technology company’s stock worth $13,030,000 after buying an additional 5,042 shares in the last quarter. QRG Capital Management Inc. increased its stake in Veeva Systems by 15.7% during the second quarter. QRG Capital Management Inc. now owns 12,771 shares of the technology company’s stock valued at $3,678,000 after acquiring an additional 1,735 shares during the period. Nordea Investment Management AB raised its holdings in Veeva Systems by 9.3% in the 2nd quarter. Nordea Investment Management AB now owns 391,273 shares of the technology company’s stock valued at $110,832,000 after acquiring an additional 33,378 shares in the last quarter. Finally, Teacher Retirement System of Texas raised its holdings in Veeva Systems by 1.9% in the 2nd quarter. Teacher Retirement System of Texas now owns 143,469 shares of the technology company’s stock valued at $41,316,000 after acquiring an additional 2,659 shares in the last quarter. Institutional investors and hedge funds own 88.20% of the company’s stock.

Veeva Systems Stock Up 0.5%

Shares of VEEV stock opened at $293.24 on Friday. The company has a market capitalization of $48.06 billion, a P/E ratio of 60.21, a P/E/G ratio of 2.22 and a beta of 0.98. Veeva Systems Inc. has a 12-month low of $201.54 and a 12-month high of $310.50. The firm has a 50-day moving average price of $288.89 and a 200 day moving average price of $277.35.

Veeva Systems (NYSE:VEEV) last issued its quarterly earnings data on Wednesday, August 27th. The technology company reported $1.26 earnings per share for the quarter, missing the consensus estimate of $1.90 by ($0.64). The firm had revenue of $789.08 million for the quarter, compared to the consensus estimate of $768.49 million. Veeva Systems had a return on equity of 13.72% and a net margin of 27.29%.Veeva Systems’s quarterly revenue was up 16.7% compared to the same quarter last year. During the same period in the prior year, the company posted $1.62 earnings per share. Veeva Systems has set its Q3 2026 guidance at 1.940-1.950 EPS. FY 2026 guidance at 7.780-7.780 EPS. As a group, research analysts expect that Veeva Systems Inc. will post 4.35 earnings per share for the current year.

Insiders Place Their Bets

In related news, insider Thomas D. Schwenger sold 3,350 shares of the business’s stock in a transaction that occurred on Thursday, October 2nd. The shares were sold at an average price of $300.04, for a total value of $1,005,134.00. Following the completion of the transaction, the insider owned 23,773 shares in the company, valued at $7,132,850.92. The trade was a 12.35% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Eleni Nitsa Zuppas sold 6,000 shares of the company’s stock in a transaction on Tuesday, October 7th. The stock was sold at an average price of $306.62, for a total value of $1,839,720.00. Following the transaction, the insider directly owned 25,325 shares in the company, valued at approximately $7,765,151.50. This represents a 19.15% decrease in their position. The SEC filing for this sale provides additional information. Over the last quarter, insiders have sold 24,665 shares of company stock valued at $7,438,000. 10.30% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

A number of analysts have recently issued reports on the company. Oppenheimer restated an “outperform” rating and set a $325.00 price objective on shares of Veeva Systems in a research report on Thursday, August 28th. Raymond James Financial reissued an “outperform” rating and issued a $340.00 price target (up previously from $310.00) on shares of Veeva Systems in a report on Thursday, August 28th. Barclays raised their price objective on shares of Veeva Systems from $300.00 to $325.00 and gave the stock an “overweight” rating in a report on Thursday, August 28th. Canaccord Genuity Group increased their price target on shares of Veeva Systems from $270.00 to $300.00 and gave the stock a “hold” rating in a research report on Thursday, August 28th. Finally, TD Cowen upgraded shares of Veeva Systems from a “hold” rating to a “buy” rating and raised their price target for the stock from $297.00 to $380.00 in a research note on Tuesday, October 7th. Seventeen research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat, Veeva Systems currently has a consensus rating of “Moderate Buy” and a consensus price target of $307.28.

Veeva Systems Profile

Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.